Your browser doesn't support javascript.
loading
Current status and prospect of treatments for recurrent hepatocellular carcinoma.
Yang, Yu-Qing; Wen, Zhen-Yu; Liu, Xiao-Yan; Ma, Zhen-Hu; Liu, Yan-E; Cao, Xue-Ying; Hou, Li; Xie, Hui.
Afiliación
  • Yang YQ; Department of Epidemiology and Biostatistics, Jilin University, Changchun 130021, Jilin Province, China.
  • Wen ZY; Department of Occupational and Environmental Health, Jilin University, Changchun 130021, Jilin Province, China.
  • Liu XY; Senior Department of Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
  • Ma ZH; Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
  • Liu YE; Department of Epidemiology and Biostatistics, Jilin University, Changchun 130021, Jilin Province, China.
  • Cao XY; Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
  • Hou L; Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
  • Xie H; Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China. xh302jr@126.com.
World J Hepatol ; 15(2): 129-150, 2023 Feb 27.
Article en En | MEDLINE | ID: mdl-36926237
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Hepatol Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Hepatol Año: 2023 Tipo del documento: Article País de afiliación: China